SCHEMBL6132840

SCHEMBL6132840

CCOC(=O)C(Cc1ccc(C)c(C)c1)(NC(C)=O)C(=O)OCC

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.68
RECQL P46063 1/20 0.68
PKM P14618 2/20 0.53
KDM4E B2RXH2 1/20 0.53
THRB P10828 2/20 0.51
MAPT P10636 3/20 0.50
ATM Q13315 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
HTT P42858 2/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
MAPK1 P28482 1/20 0.50
PTPRB P23467 2/20 0.43
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
ACP1 P24666 1/20 0.40
TAAR1 Q96RJ0 1/20 0.40
POLB P06746 2/20 0.39
MMP8 P22894 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5361411 0.88 ALDH1A1 (0.64) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL5359731 0.88 ALDH1A1 (0.64) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL5366575 0.87 ALDH1A1 (0.62) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL3279109 0.85 ALDH1A1 (0.67) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL25942340 0.84 ALDH1A1 (0.74) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL11124323 0.84 ALDH1A1 (0.78) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL5365451 0.84 ALDH1A1 (0.65) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL9261475 0.84 ALDH1A1 (0.65) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL6782409 0.83 ALDH1A1 (0.76) ALDH1A1RECQLPKMKDM4ETHRB
SCHEMBL9556731 0.83 ALDH1A1 (0.76) ALDH1A1RECQLPKMKDM4ETHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6924278-B2 Heterocyclic carboxy amines such as (2R)-1-[3,5-Bis(trifluoromethyl)benzoyl]-4-[4-((3S)-3-ethylmorpholino)-2-butynyl]-2-[(1H-indol-3-yl)methyl]piperazine, used as substance P and neurokinin antagonist for prophylaxis of diseases FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-08-02 US disclosed
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-02-03 US disclosed
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-06-19 US disclosed
EP-0993457-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-04-19 EP disclosed
WO-1998057954-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050027121-A1 Aroyl-piperazine derivatives, their preparation and their use as tachykinin antagonists TAC3, TACR1, SSTR5 ALDH1A1 2608/4885RECQL 4557/4885PKM 814/4885
US-20030114668-A1 AROYL-PIPERAZINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS TACHYKININ ANTAGONISTS TACR1, NPSR1, SSTR2 ALDH1A1 1903/4885RECQL 3240/4885PKM 1102/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.